Submitted by Anonymous (not verified) on 2 October 2025 - 15:20
Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Date of authorisation: 15/09/2023, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Date of authorisation: 15/09/2023, Revision: 5, Status: Authorised